DE69808303T2 - Verfahren zur verbesserung der bioverfügbarkeit des fexofenadins und seiner derivate - Google Patents

Verfahren zur verbesserung der bioverfügbarkeit des fexofenadins und seiner derivate

Info

Publication number
DE69808303T2
DE69808303T2 DE69808303T DE69808303T DE69808303T2 DE 69808303 T2 DE69808303 T2 DE 69808303T2 DE 69808303 T DE69808303 T DE 69808303T DE 69808303 T DE69808303 T DE 69808303T DE 69808303 T2 DE69808303 T2 DE 69808303T2
Authority
DE
Germany
Prior art keywords
fexofenadine
derivatives
improving
bio availability
bio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69808303T
Other languages
English (en)
Other versions
DE69808303D1 (de
Inventor
Kin-Kai Hwang
Dennis H Giesing
Gail H Hurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69808303D1 publication Critical patent/DE69808303D1/de
Publication of DE69808303T2 publication Critical patent/DE69808303T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69808303T 1997-08-14 1998-07-21 Verfahren zur verbesserung der bioverfügbarkeit des fexofenadins und seiner derivate Expired - Lifetime DE69808303T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (2)

Publication Number Publication Date
DE69808303D1 DE69808303D1 (de) 2002-10-31
DE69808303T2 true DE69808303T2 (de) 2003-05-22

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808303T Expired - Lifetime DE69808303T2 (de) 1997-08-14 1998-07-21 Verfahren zur verbesserung der bioverfügbarkeit des fexofenadins und seiner derivate

Country Status (30)

Country Link
EP (1) EP1003528B1 (de)
JP (1) JP4295913B2 (de)
KR (1) KR100522985B1 (de)
CN (1) CN1143680C (de)
AR (1) AR018505A1 (de)
AT (1) ATE224721T1 (de)
AU (1) AU725965C (de)
BR (1) BR9811937A (de)
CA (1) CA2301267C (de)
CZ (1) CZ293666B6 (de)
DE (1) DE69808303T2 (de)
DK (1) DK1003528T3 (de)
EE (1) EE04263B1 (de)
ES (1) ES2179523T3 (de)
HK (1) HK1025901A1 (de)
HU (1) HU226823B1 (de)
ID (1) ID24463A (de)
IL (1) IL134521A (de)
NO (1) NO325148B1 (de)
NZ (1) NZ502133A (de)
OA (1) OA11287A (de)
PL (1) PL191607B1 (de)
PT (1) PT1003528E (de)
RU (1) RU2197967C2 (de)
SK (1) SK283868B6 (de)
TR (1) TR200000419T2 (de)
TW (1) TWI240633B (de)
UA (1) UA64765C2 (de)
WO (1) WO1999008690A1 (de)
ZA (1) ZA987221B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9706449A (es) * 1995-02-28 1997-11-29 Hoechst Marion Roussel Inc Composicion farmaceutica para compuestos de piperidinalcanol.
ATE238773T1 (de) * 1997-08-26 2003-05-15 Aventis Pharma Inc Arzneimittel für die kombination piperidinoalkanol-dekongestivum
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
BR0306329A (pt) * 2002-05-29 2005-04-26 Aventis Pharmaceuticals Holdin Método de tratamento de asma
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
BR112013029778A2 (pt) 2011-05-20 2017-01-17 Aventis Pharma Inc composição farmacêutica que compreende fexofenadina
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides

Also Published As

Publication number Publication date
EE200000069A (et) 2000-10-16
PL338579A1 (en) 2000-11-06
CA2301267A1 (en) 1999-02-25
CZ2000522A3 (cs) 2000-09-13
ZA987221B (en) 1999-02-15
CZ293666B6 (cs) 2004-06-16
RU2197967C2 (ru) 2003-02-10
PL191607B1 (pl) 2006-06-30
CN1267221A (zh) 2000-09-20
HU226823B1 (hu) 2009-11-30
IL134521A0 (en) 2001-04-30
AR018505A1 (es) 2001-11-28
NO20000706D0 (no) 2000-02-11
DK1003528T3 (da) 2003-02-03
WO1999008690A1 (en) 1999-02-25
BR9811937A (pt) 2000-09-05
NZ502133A (en) 2002-03-28
JP4295913B2 (ja) 2009-07-15
KR100522985B1 (ko) 2005-10-21
CA2301267C (en) 2004-07-13
AU725965B2 (en) 2000-10-26
HUP0003189A2 (en) 2001-03-28
AU725965C (en) 2004-04-22
TR200000419T2 (tr) 2000-09-21
ES2179523T3 (es) 2003-01-16
IL134521A (en) 2005-07-25
ATE224721T1 (de) 2002-10-15
AU8505098A (en) 1999-03-08
HUP0003189A3 (en) 2001-04-28
ID24463A (id) 2000-07-20
UA64765C2 (uk) 2004-03-15
HK1025901A1 (en) 2000-12-01
CN1143680C (zh) 2004-03-31
EP1003528B1 (de) 2002-09-25
EP1003528A1 (de) 2000-05-31
OA11287A (en) 2003-10-22
SK283868B6 (sk) 2004-03-02
SK1842000A3 (en) 2000-08-14
EE04263B1 (et) 2004-04-15
TWI240633B (en) 2005-10-01
KR20010022845A (ko) 2001-03-26
PT1003528E (pt) 2003-02-28
NO20000706L (no) 2000-04-13
JP2001515041A (ja) 2001-09-18
DE69808303D1 (de) 2002-10-31
NO325148B1 (no) 2008-02-11

Similar Documents

Publication Publication Date Title
DE60039177D1 (de) Verfahren zur verbesserung der haut und des pelzes von haustieren
DE60035733D1 (de) Einrichtung und Verfahren zur quantitativen Bestimmung der Aenderung in einem Elektrokardiogrammsignal
DE69829181D1 (de) Verbesserte trennsäulen und verfahren zur herstellung der verbesserten trennsäulen
DE60210265D1 (de) Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
DE59810535D1 (de) Verfahren zur bestimmung von parametern der hämodialyse und vorrichtung zur durchführung des verfahrens
DE60027405D1 (de) Verfahren zur steigerung der aktivität von haustieren
DE69735540D1 (de) Verfahren zur Minimierung der Kosten von Online-Zugriff
DE69805112D1 (de) Biosensor und Verfahren zur Herstellung desselben
DE69700253D1 (de) Verfahren und Vorrichtung zur Bestimmung der Konzentration eines Bestandteils
DE59902062D1 (de) Verbessertes verfahren zur gleichzeitigen herstellung von 6-aminocapronitril und hexamethylendiamin
DE69812232T2 (de) Beschichtungszusammensetzung und Verfahren zur Beschichtung
DE69822873D1 (de) Zusammensetzungen und verfahren zur gewichtsverringerung
DE59913665D1 (de) Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten
DE60028684D1 (de) Verfahren und Anordnung zur Bestimmung der Anzahl von Teilentladungsquellen
DE69808303T2 (de) Verfahren zur verbesserung der bioverfügbarkeit des fexofenadins und seiner derivate
DE60033941D1 (de) Neuartiges verfahren zur herstellung von l-epi-2-inosose und neuartiges verfahren zur herstellung von epi-inositol
DE60029697D1 (de) Febrifugin und ispofebrifugin und verfahren zur herstellung der beiden
DE69724801D1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE50003293D1 (de) Verfahren und vorrichtung zum härten der lagerflächen von kurbelwellen
DE69836105D1 (de) Nagel und Verfahren zu seiner Herstellung
DE69821764D1 (de) Festkörperreiche beschichtungszusammensetzung und verfahren zur decklackierung
DE59903004D1 (de) Verfahren und Vorrichtung zur Ermitttlung der Gewichtskraft von Ballen
DE59806380D1 (de) Verfahren zur Abstandsmessung und Durchführung des Verfahrens
DE59907216D1 (de) Verbessertes verfahren zur gleichzeitigen herstellung von 6-aminocapronitril und hexamethylendiamin
DE69907540D1 (de) Verfahren zur Herstellung von D-Alloisoleucin und Zwischenprudukte zu seiner Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US